Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Still trying to adjust to the post-COVID world

Healius
3:27pm
February 22, 2024
FY24 underlying profit has been downgraded by double digits, given lower 2H expectations for Pathology volumes and benefits. While 1Q saw high single -digit Pathology volumes and double-digit benefit growth, momentum faded in 2Q, with both metrics tracking in the low single-digit range. It appears soft GP attendances, coupled with labour shortages and inflationary pressures, continue to conspire in holding back volumes. While management is aiming to accelerate Pathology restructuring to better match volumes with costs, activity to date seems to have done little to move the dial, putting greater uncertainty around a solution and complete near-term turnaround. We lower our FY24-26 estimates, with our target price decreasing to A$1.37. Hold.

Less than compelling

Clinuvel Pharmaceuticals
3:27pm
February 22, 2024
CUV’s posted a weaker than expected 1H24 result, with negligible top-line growth combined with a significant increase in the cost base (clinical activity, staff retention incentives and an increase in service roles) to meet future demand. While the top-line growth was disappointing, paired with large cost base increases and Board turnover it failed to inspire much confidence. Investors remain in the dark on US vs EU performance outside of cursory commentary. There was no discussion around capital management plans outside of stockpiling cash, now ~25% of the market cap. We downgrade our target price to A$16 p/s (from A$22 p/s) and recommendation moves to Hold, noting increased risk around board and disclosure. Traders may find an opportunity down here, but equally prepared to wait until a number of investor concerns are addressed.

Wasn’t RIO supposed to buy everyone?

Rio Tinto
3:27pm
February 21, 2024
An in-line CY23 result, although RIO hasn’t been immune to weakening metal prices (ex-iron ore) and global inflation pressures. Looks can be deceiving, but RIO commentary continues to run contrary to a popular view that the big miner might be an aggressive acquirer pursuing M&A. Despite the challenges, and capex in OTUG, RIO still generated FCF of US$7.7bn in CY23. We maintain a Hold rating on RIO, with a A$127ps Target Price.

Stage one done

IRESS
3:27pm
February 21, 2024
IRE reported FY23 in-line with guidance: revenue of A$625.7m (+1.6%); and underlying EBITDA of A$128.3m (top-end of previous guidance). Whilst FY24 and exit run-rate ‘underlying’ EBITDA guidance was upgraded, IRE somewhat shifted the goal posts. ‘Adjusted’ EBITDA expectations now include ongoing project related costs of ~A$20m previously expected to be non-recurring. Positives included all divisions, excluding Super, showing hoh EBITDA growth; and confidence in two divestments. We expect significant de-leverage in 2H24. We can see an ongoing path for improvement for IRE and a material divestment (Mortgages) is a relatively near-term catalyst. However, after a solid re-rate and lower clarity on ‘base’ free cash flow generation post this result, we move to Hold.

A transitional period with some seasonal elements

Camplify Holdings
3:27pm
February 21, 2024
Camplify’s (CHL) 1H24 result beat our GTV/revenue forecasts (+4-8%) showing robust pcp growth (+~95%). Excl. ~A$0.9m of one-off MyWay setup and platform integration costs, normalised EBITDA was -A$1.4m (vs -A$1.8m in the pcp). The stock closed down ~17% on result day, which we largely attribute to some seasonality in CHL’s key headline metrics (future bookings, gross margins, etc). We make several cost and margin assumption changes over the forecast period (details below). Our price target remains unchanged at A$2.85 and we maintain an Add recommendation on the stock.

Rebasing expectations

Corporate Travel Management
3:27pm
February 21, 2024
1H24 was broadly in line with our forecast but was below consensus estimates. Due to 2Q macro issues and the UK Bridging contract materially underperforming expectations, CTD has revised its FY24 EBITDA guidance by 15.4% at the mid-point. Off this new base, CTD has a five-year strategy to double profits by FY29. The quantum of the earnings downgrade is clearly disappointing. Given the aggressive pivot in earnings guidance from the AGM last year, the market may take time to rebuild its confidence in the outlook. However, if CTD delivers even close to its five-year strategy, the share price will be materially higher in time. We maintain an Add rating with a new price target of A$20.65.

Consistent as always

Acrow
3:27pm
February 21, 2024
ACF’s 1H24 result was comfortably above our expectations. Key positives: EBITDA margin increased 570bp to 34.8%; Annualised return on investment (ROI) on growth capex of 58% was well above management’s target of >40%; Bad debt expense fell to 1% of sales vs 1.8% of sales in FY23. Key negative: ND/EBITDA increased slightly to 1.2x (vs 1.0x at FY23), although this was largely due to the MI Scaffold acquisition with the business only contributing two-months to earnings in the half. Management has maintained guidance for FY24 EBITDA of between $72-75m. As a result, we make minimal changes to FY24-26 earnings forecasts. Our target price rises to $1.40 (from $1.22) largely due to a roll-forward of our model to FY25 forecasts and we maintain our Add rating. Trading on 8.6x FY25F PE and 5% yield with strong business momentum and leverage to growing civil infrastructure activity over the long term, ACF remains one of our key picks in the small caps space.

Charging up operational capacity

SmartGroup
3:27pm
February 21, 2024
SIQ reported FY23 NPATA +3% to A$63.2m, in-line with expectations. 2H23 reflects the commencement of EV-policy led demand flowing through – revenue +15.7% and NPATA +14.7% hoh. Lease demand accelerated hoh and SIQ is scaling up operating capacity to execute (~17% hoh cost growth; margins down 80bps hoh). Near-term earnings growth is highly visible, with a material contract to also contribute from FY25. There remains a material opportunity to drive lease uptake and earnings under the current EV policy (expected review date of 2027). However, we view SIQ’s valuation currently captures the near-term (FY24) expectations and we retain a Hold. The main risk is any unplanned early removal of the current EV policy (election risk), post a period of operational expansion.

Australian Food is under pressure too

Woolworths
3:27pm
February 21, 2024
While WOW’s 1H24 result was in line with expectations following the company’s trading update in January, commentary on sales for the first seven weeks and divisional guidance for 2H24 was softer-than-anticipated. Key positives: WooliesX earnings jumped 132% reflecting increased demand for convenience and productivity improvements; Operating cash flow increased 20% with ND/EBITDA improving to 2.5x (FY23: 2.6x). Key negatives: Inflation continued to moderate and consumers are becoming more cautious; Customers continued to reduce discretionary spending and Woolworths Supermarkets was losing market share in discretionary everyday needs categories such as pets, baby care and home essentials. CEO Brad Banducci has announced his retirement with Amanda Bardwell (current Managing Director of WooliesX) to take over in September. We adjust FY24/25/26F group underlying EBIT by -2%/-3%/-3%. Our target price decreases to $34.70 (from $39.45) and we downgrade our rating to Hold (from Add). With NZ Food and BIG W already facing tough operating conditions, the soft start to 2H24 for Australian Food and loss of market share in non-food is a concern. WOW is now trading on 22.2x FY25F PE and 3.3% yield. With an increasingly uncertain outlook, we have become more cautious on the stock with downside risk if the trading environment continues to deteriorate.

Dividend surprise

Santos
3:27pm
February 21, 2024
STO posted a CY23 earnings result that on balance was on the softer side, although materially beat on its dividend. CY23 cash dividend will total US26.2ps, well above our estimate of US20cps. All growth projects remain on track, with Barossa first gas in 2025, Pikka Phase 1 first oil in 2026, and Moomba CCS first injection in mid-CY24. No changes to CY24 production or cost guidance. Strategic review process is ongoing, with no updates ready to include with the CY23 result. Further volatility could yield a better entry opportunity, maintain Hold rating.

News & Insights

Treasury Secretary Scott Bessent’s adept negotiation of a US-China tariff deal and his method for assessing tariffs’ modest impact on inflation, using a 20.5% effective rate, position him as a formidable successor to Henry Morganthau’s legacy.

In the 1930s, the US Treasury Secretary Henry Morganthau was widely regarded as the finest Treasury Secretary since Alexander Hamilton. However, if the current Treasury Secretary Scott Bessent, continues to deliver results as he is doing now, he will provide formidable competition to Morganthau’s legacy.

The quality of Bessent’s work is exceptional, demonstrated by his ability to secure an agreement with China in just a few days in complex circumstances.

The concept of the "effective tariff rate" is a term that has gained traction recently. Although nominal tariff rates on individual goods in individual countries might be as high as 100% or 125%; the effective tariff rate, which reflects the actual tariffs the US imposes on imports from all countries, is thought to be only 20.5%. This figure comes from an online spreadsheet published by Fitch Ratings, since 24 April.

Finch Ratings Calculator Screenshot

This effective tariff rate of 20.5% can be used in assessing the impact of import tariffs on US inflation. To evaluate this, I used a method proposed by Scott Bessent during his Senate confirmation hearing. Bessent began by noting that imports account for only 16% of US goods and services that are consumed in the US Economy. In this case, a 10% revenue tariff would increase domestic prices by just 1.6%. With a core inflation rate of 2.8% in the US, this results in a headline inflation rate of 4.4%. Thus, the overall impact of such tariffs on the US economy is relatively modest.

A couple of weeks ago, Austan Goolsbee, the President of the Chicago Fed, noted that tariffs typically increase inflation, which might prompt the Fed to lift rates, but they also reduce economic output, which might prompt the Fed to rate cuts. Consequently, Goolsbee suggested that the Federal Reserve might opt to do nothing. This prediction was successful when the Open Market Committee of the Fed, with Goolsbee as a member, left the Fed Funds rate unchanged last week.

A 90-day agreement between the US and China, masterfully negotiated by Scott Bessent, has dramatically reduced tariffs between China and the US. China now only imposes a 10% import tariff on the US, while the US applies a 30% tariff on Chinese goods—10% as a revenue tariff and 20% to pressure China to curb the supply of fentanyl ingredients to third parties in Mexico or Canada. It is this fentanyl which fuels the US drug crisis. This is a priority for the Trump administration.

How Import Tariffs Affect US Inflation.

We can calculate how much inflation a tariff adds to the US economy in the same way as Scott Bessent by multiplying the effective tariff rate by the proportion that imports are of US GDP. Based on a 20.5% US effective tariff rate, I calculated that it adds 3.28% to the US headline Consumer Price Index (CPI). This results in a US headline inflation rate of 6.1% for the year ahead. In Australia, we can draw parallels to the 10% GST introduced 24 years ago, where price effects were transient and vanished after a year, avoiding sustained high inflation.

Before these negotiations, the US was levying a nominal tariff on China of 145%. Some items were not taxed, so meant that the effective tariff on China was 103%. Levying this tariff meant that the US faced a price effect of 3.28%, contributing to a 6.1% headline inflation rate.

If the nominal tariff rate dropped to 80%, the best-case scenario I considered previously, the price effect would fall to 2.4%, with a headline US inflation rate of 5.2%. With the US now charging China a 30% tariff, this adds only 2% to headline inflation, yielding a manageable 4.8% US inflation rate.

As Goolsbee indicated, the Fed might consider raising interest rates to counter inflation or cutting them to address reduced output, but ultimately, it is likely to maintain current rates, as it did last week. I anticipate the Fed will continue to hold interest rates steady but with an easing bias, potentially cutting rates in the second half of the year once the situation stabilises.

My current Fed Funds rate model suggests that, absent this year's tariff developments, the Fed would have cut rates by 50 basis points. This could be highly positive for the US economy.

Read more
In a lively presentation to the Economic Club of New York, Federal Reserve Bank of Chicago President Austan Goolsbee highlighted tariffs as a minor stagflation risk but emphasized strong U.S. GDP growth of around 2.6%, suggesting a resilient economy and potential for a soft landing.

I’d like to discuss a presentation delivered by Austan Goolsbee, President of the Federal Reserve Bank of Chicago, to the Economic Club of New York on 10 April. Austan Goolsbee, gave a remarkably animated talk about tariffs and their impact on the U.S. economy.

Goolsbee is a current member of the Federal Reserve’s Open Market Committee, alongside representatives from Washington, D.C., and Fed bank Presidents from Chicago, Boston, St. Louis, and Kansas City.  

Having previously served as Chairman of the Council of Economic Advisers in the Obama White House, Goolsbee’s presentation style in New York was notably different from his more reserved demeanour I had previously seen when I had attended a talk of his in Chicago.

During his hour-long, fast-paced talk, Goolsbee addressed the economic implications of tariffs. He recounted an interview where he argued that raising interest rates was not the appropriate response to tariffs, a stance that led some to label him a “Dove.” He humorously dismissed the bird analogy, instead likening himself to a “Data Dog,” tasked with sniffing out the data to guide decision-making.

Goolsbee explained that tariffs typically drive inflation higher, which might ordinarily prompt rate hikes. However, they also tend to reduce economic growth, suggesting a need to cut rates. This creates a dilemma where rates might not need adjustment at all. He described tariffs as a “stagflation event” but emphasised that their impact is minor compared to the severe stagflation of the 1970s.

When asked if the U.S. was heading towards a recession, Goolsbee said that the "hard data" was surprisingly strong.

Let us now look at our model of US GDP based on the Chicago Fed National Activity Index. This Index   incorporates 85 variables across production, sales, employment, and personal consumption.  In the final quarter of last year, this index indicated the GDP growth was slightly below the long-term average, suggesting a US GDP growth rate of 1.9% to 2%.

However, data from the first quarter of this year showed stronger growth, just fractionally below the long-term trend.

Using Our Chicago Fed model, we find that US GDP growth had risen from about 2% growth to a growth rate of around 2.6%, indicating a robust U.S. economy far from recessionary conditions.

Model of US GDP

We think that   increased government revenue from Tariffs might temper domestic demand, potentially guiding growth down towards 1.9% or 2% by year’s end. Despite concerns about tariffs triggering a downturn, this highlights the economy’s resilience and suggests   a “soft landing,” which could allow interest rates to ease, weaken the U.S. dollar, and boost demand for equities.

We will provide monthly reviews of these indicators. We note that, for now, the outlook for the U.S. economy remains very positive.

Read more
This discussion simplifies the US business cycle, highlighting how tariffs are projected to lower growth to 1.8% in 2025, reduce the budget deficit, and foster an extended soft landing, boosting equities and commodities through 2027.


I want to discuss a simplified explanation of the US business cycle, prompted by the International Monetary Fund's forecast released yesterday, which, for the first time, assessed the impact of tariffs on the US economy. Unlike last year's 2.8% growth, the IMF predicts a drop to 1.8% in 2025. This is slightly below my forecast of 1.9 to 2%. They further anticipate growth will decline to 1.7% in 2026, lower than my previous estimate of 2%. Growth then returns to 2% by 2027.

This suggests that increased tariffs will soften demand, but the mechanism is intriguing. Tariffs are expected to reduce the US budget deficit from about 7% of GDP to around 5%, stabilizing government debt, though more spending cuts are needed.  This reduction in US deficit reduces US GDP growth. This leads to a slow down.

The revenue from tariffs is clearly beneficial for the US budget deficit, but the outlook for the US economy now points to an extended soft landing. This is the best environment for equities and commodities over a two-year view. With below-trend growth this year and even softer growth next year, interest rates are expected to fall, leading the fed funds rate to drift downward in response to slower growth trends. Additionally, the US dollar is likely to weaken as the Fed funds rate declines, following a traditional US trade cycle model: falling interest rates lead to a weaker currency, which in turn boosts commodity prices.

This is particularly significant because the US is a major exporter of agricultural commodities, has rebuilt its oil industry, and is exporting LNG gas. The rising value of these commodities stimulates the economy, boosting corporate profits and setting the stage for the next surge in growth in a couple of years.

This outlook includes weakening US interest rates and rising commodity prices, continuing through the end of next year. This will be combined with corporate tax cuts, likely to be passed in a major bill in July, reducing US corporate taxes from 21% to 15%.  This outlook is very positive for both commodities and equities. Our model of commodity prices shows an upward movement, driven by an increase in international liquidity within the international monetary system.

With US dollar debt as the largest component in International reserves , as US interest rates fall, the creation of US government debt accelerates, increasing demand for commodities.  The recent down cycle in commodities is now transitioning to an extended upcycle through 2026 and 2027, fueled by this increased liquidity due to weaker interest rates.

Furthermore, the rate of growth in international reserves is accelerating, having reached a long-term average of about 7% and soon expected to rise to around 9%. Remarkably, the tariffs are generating a weaker US dollar, which drives the upward movement in commodity prices. This improvement in commodity prices is expected to last for at least the next two years, and potentially up to four years.

Read more